project id: TCGA-PRAD; case submitter id: TCGA-EJ-7218; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; age at index: 71; days to birth: -26181; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1935; age at diagnosis: 26181; ajcc clinical m: M0; ajcc clinical t: T2a; ajcc pathologic n: N0; ajcc pathologic t: T2c; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2542.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 3; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 4; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; days to collection: 2397; initial weight: 850.0; oct embedded: true; sample id: a6f36349-5e5d-4d06-bba2-0792ff0f0ee3; sample submitter id: TCGA-EJ-7218-01B; slide id: b975c08c-6576-48e2-a00e-bbb6281f6deb; slide submitter id: TCGA-EJ-7218-01B-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0; section location: TOP;